<qa>  What is the primary end-point of the measure of the rate of caudate atrophyThe primary end-point will be the measure of the rate of caudate atrophy - the most sensitive biomarker identified to date in HD - after one year of treatment with resveratrol in early affected HD patients using volumetric MRI as we described. 